VMP 9306011000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Galantamine 8mg modified-release capsules
BNF code 0411000F0AAAEAE
Virtual Therapeutic Moiety Galantamine
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Galantamine hydrobromide
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 395727007
Strength value numerator 8.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsulemodified-release.oral
Dose Form
Formulation Modified-release capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Gaalin 8mg modified-release capsules (Milpharm Ltd)
Galantamine 8mg modified-release capsules (Krka UK Ltd)
Galzemic XL 8mg capsules (Zentiva Pharma UK Ltd)
Gatalin XL 8mg capsules (Aspire Pharma Ltd)
Gazylan XL 8mg capsules (Teva UK Ltd)
Lotprosin XL 8mg capsules (Accord-UK Ltd)
Luventa XL 8mg capsules (Fontus Health Ltd)
Reminyl XL 8mg capsules (Sigma Pharmaceuticals Plc)
Reminyl XL 8mg capsules (Takeda UK Ltd)
Virtual Medicinal Product Packs
Galantamine 8mg modified-release capsules 28 capsule

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback